|
|
Volumn 122, Issue 6, 2013, Pages 1088-1089
|
|
Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BONE MARROW;
BONE MARROW CELL;
CLINICAL PRACTICE;
CYTOLOGY;
FLOW CYTOMETRY;
HUMAN;
LETTER;
METHODOLOGY;
MINIMAL RESIDUAL DISEASE;
MULTIPLE MYELOMA;
PATHOLOGY;
QUESTIONNAIRE;
STATISTICS;
TREATMENT OUTCOME;
UNITED STATES;
BONE MARROW;
BONE MARROW CELLS;
FLOW CYTOMETRY;
HUMANS;
MULTIPLE MYELOMA;
NEOPLASM, RESIDUAL;
PHYSICIAN'S PRACTICE PATTERNS;
QUESTIONNAIRES;
TREATMENT OUTCOME;
UNITED STATES;
MLCS;
MLOWN;
|
|
EID: 84886921631
PISSN: None
EISSN: 15280020
Source Type: None
DOI: 10.1182/blood-2013-05-506170 Document Type: Letter |
|
Times cited : (86)
|
|
References (0)
|
